看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | 20.6x - 22.8x | 21.7x |
| Selected Fwd P/E Multiple | 3.6x - 3.9x | 3.8x |
| Fair Value | CHF 57.95 - CHF 64.05 | CHF 61 |
| Upside | -16.6% - -7.8% | -12.2% |
| Benchmarks | - | Full Ticker |
| Alpha Trust Andromeda Investment Trust S.A. | - | ATSE:ANDRO |
| HBM Healthcare Investments AG | - | SWX:HBMN |
| BB Biotech AG | - | SWX:BION |
| Apax Global Alpha Limited | - | DB:7AP |
| Quest for Growth NV | - | ENXTBR:QFG |
| Private Equity Holding AG | - | SWX:PEHN |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| ANDRO | HBMN | BION | 7AP | QFG | PEHN | |||
| ATSE:ANDRO | SWX:HBMN | SWX:BION | DB:7AP | ENXTBR:QFG | SWX:PEHN | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | -35.5% | -47.5% | NM- | -3.0% | ||
| 3Y CAGR | 93.9% | NM- | NM- | -71.0% | NM- | -38.3% | ||
| Latest Twelve Months | -44.3% | 249.5% | 136.7% | -84.3% | -79.8% | 244.5% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 61.9% | 86.1% | -1295975.4% | 39.0% | 73.2% | 77.1% | ||
| Prior Fiscal Year | 324.2% | 102.9% | -590305.7% | 79.7% | 195.2% | -58.7% | ||
| Latest Fiscal Year | 71.7% | -36.3% | 68.0% | 42.6% | 169.0% | 81.3% | ||
| Latest Twelve Months | 63.7% | 98.3% | 68.0% | 42.6% | 169.0% | 64.4% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -2.1x | NA | NA | NA | NA | NA | ||
| Price / LTM Sales | 3.8x | 5.3x | 13.0x | 32.7x | -19.7x | 16.8x | ||
| LTM P/E Ratio | 6.0x | 5.4x | 19.2x | 76.7x | -11.7x | 26.1x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -11.7x | 6.0x | 76.7x | |||||
| Historical LTM P/E Ratio | 1.7x | 9.9x | 24.8x | |||||
| Selected P/E Multiple | 20.6x | 21.7x | 22.8x | |||||
| (x) LTM Net Income | 7 | 7 | 7 | |||||
| (=) Equity Value | 147 | 154 | 162 | |||||
| (/) Shares Outstanding | 2.5 | 2.5 | 2.5 | |||||
| Implied Value Range | 59.38 | 62.51 | 65.64 | |||||
| FX Rate: EUR/CHF | 1.1 | 1.1 | 1.1 | Market Price | ||||
| Implied Value Range (Trading Cur) | 55.53 | 58.45 | 61.38 | 69.50 | ||||
| Upside / (Downside) | -20.1% | -15.9% | -11.7% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | ANDRO | HBMN | BION | 7AP | QFG | PEHN | |
| Value of Common Equity | 23 | 1,177 | 1,492 | 636 | 71 | 183 | |
| (/) Shares Outstanding | 3.5 | 6.8 | 54.8 | 485.5 | 18.7 | 2.5 | |
| Implied Stock Price | 6.72 | 173.80 | 27.25 | 1.31 | 3.81 | 74.32 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.07 | |
| Implied Stock Price (Trading Cur) | 6.72 | 173.80 | 27.25 | 1.31 | 3.81 | 69.50 | |
| Trading Currency | EUR | CHF | CHF | EUR | EUR | CHF | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.07 | |